Optiray 350 741 mg/mL (Ioversol INJECTION) 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast agent used for imaging procedures. This injection, containing ioversol, aids in enhancing visibility during diagnostic imaging. Ideal for intra-arterial and intravenous use, it supports clear visualization of blood vessels and organs.

Strength

741 mg/mL

Pack Size

20 SYRINGE, PLASTIC in 1 CARTON (0019-1333-81) / 125 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Liebel-Flarsheim Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Optiray 350 741 mg/mL is primarily used as a contrast medium in medical imaging. It helps improve the visibility of blood vessels and organs during procedures like angiography and computed tomography (CT) scans. This ioversol-based injection is designed for intra-arterial and intravenous administration, making it versatile for various diagnostic needs. What is Optiray 350 used for? It is commonly employed to enhance the clarity of images, aiding healthcare professionals in accurate diagnosis.

Side Effects

When administered, Optiray 350 741 mg/mL may cause temporary side effects such as warmth or flushing. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly. It is important to monitor for any unusual reactions and consult a healthcare provider if concerns arise.

Precautions & Warnings

Handling Optiray 350 741 mg/mL requires adherence to standard safety protocols. Ensure the injection is stored properly and used within its shelf life. Always follow the manufacturer's guidelines for preparation and administration. It is crucial to inform healthcare providers of any known allergies or sensitivities before use.

Avoid Interactions

Optiray 350 741 mg/mL may interact with certain medications or substances. It is advisable to avoid alcohol consumption before and after administration. Additionally, individuals taking other contrast agents or medications should consult their healthcare provider to ensure compatibility. Always disclose your full medical history to avoid potential interactions.

Frequently Asked Questions

Optiray 350 741 mg/mL is used as a contrast agent to enhance visibility during medical imaging procedures, such as angiography and CT scans.

Optiray 350 741 mg/mL is administered via intra-arterial or intravenous injection, depending on the specific diagnostic procedure.

Common side effects may include temporary warmth, flushing, or mild discomfort at the injection site.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Optiray 350 741 mg/mL should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.